Avid Bioservices Inc (CDMO)

[entdoc]

honest abe: the best parallel is ImClone. I bought it at about $18 when it was in early stage III trial openings would lead PPHM to equivalent evaluation. It peaked at about $120, and then split, and meandered around for a while before settling in the $30s before being purchased by BMY. With PPHM it is a matter of "critical mass," which is overwhelming public and institutional focus and belief. So far PPHM has not missed a beat. It is an infinitely better property than Imclone, and should be as good as DNA. Right now the trading is laughable, but certainly a buying point in the .70-1.00 range.